Skip to main content

4 Result(s)

within Juan M. Hincapie-Castillo Remove this filter

and

  1. No Access

    Article

    Association between trajectories of adherence to endocrine therapy and risk of treated breast cancer recurrence among US nonmetastatic breast cancer survivors

    Endocrine therapy is the mainstay treatment for breast cancer (BC) to reduce BC recurrence risk. During the first year of endocrine therapy use, nearly 30% of BC survivors are nonadherent, which may increase B...

    Ching-Yuan Chang, Bobby L. Jones, Juan M. Hincapie-Castillo… in British Journal of Cancer (2024)

  2. No Access

    Article

    Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors

    To examine the association between prescription opioid use trajectories and risk of opioid use disorder (OUD) or overdose among nonmetastatic breast cancer survivors by treatment type.

    Ching-Yuan Chang, Bobby L. Jones… in Breast Cancer Research and Treatment (2024)

  3. No Access

    Article

    The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness

    The use of artificial intelligence (AI)-based tools to guide prescribing decisions is full of promise and may enhance patient outcomes. These tools can perform actions such as choosing the ‘safest’ medication,...

    Harriet Dickinson, Dana Y. Teltsch, Jan Feifel, Philip Hunt… in Drug Safety (2024)

  4. Article

    Open Access

    Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015

    Several studies have evaluated the effects of changes in isotretinoin risk mitigation programs, but little is known about actual fetal exposure rates in the context of other acne treatments.

    Yasser Albogami, Amir Sarayani, Juan M. Hincapie-Castillo… in Drug Safety (2021)

    Download PDF (742 KB) View Article